Author

Su‐on Chainansamit

Observed names: Chainansamit, Su-on, Su-On Chainansamit, Su-on Chainansamit

Institution: Khon Kaen Hospital

Observed institution: Khon Kaen Hospital

ORCID: 0000-0003-4983-5626

Observed ORCID: 0000-0003-4983-5626

OpenAlex ID: A5103209400

Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations

2021 · Kanyarat Khaeso, Sariya Udayachalerm, et al. · Frontiers in Pharmacology · 27

Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols

2015 · Panya Seksarn, Surapon Wiangnon, et al. · Asian Pacific Journal of Cancer Prevention · 25

PDF

Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group

2010 · Samart Pakakasama, Gavivann Veerakul, et al. · International Journal of Hematology · 22

Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes

2020 · Bunchoo Pongtanakul, Nongnuch Sirachainan, et al. · Journal of Neuro-Oncology · 19

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study

2019 · Piya Rujkijyanont, Apichat Photia, et al. · BMC Cancer · 15

PDF

Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group

2024 · Chalinee Monsereenusorn, Piti Techavichit, et al. · Annals of Hematology · 7

Trends in incidence and survival of childhood cancers in Khon Kaen, Thailand (2000–2019): a population-based Khon Kaen Cancer Registry study

2024 · Chanaporn Pinsuwan, Chalongpon Santong, et al. · BMC Public Health · 7

Treatment outcomes among high‐risk neuroblastoma patients receiving non‐immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group

2022 · Kunanya Suwannaying, Chalinee Monsereenusorn, et al. · Pediatric Blood & Cancer · 7

Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients

2020 · Kanyarat Khaeso, Nontaya Nakkam, et al. · Journal of Pediatric Genetics · 7

NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine

2021 · Kanyarat Khaeso, Patcharee Komvilaisak, et al. · Drug Metabolism and Pharmacokinetics · 5

Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6‐Mercaptopurine Treatment

2026 · Kanyarat Khaeso, Su‐on Chainansamit, et al. · Clinical and Translational Science · 2

PDF

Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis

2024 · Chalinee Monsereenusorn, Kunanya Suwannaying, et al. · Asian Pacific Journal of Cancer Prevention · 2

PDF

Hyperleukocytosis and Access to Minimal Residual Disease Testing Impact Outcomes in Children With Newly Diagnosed Acute Myeloid Leukemia in Thailand

2026 · Piya Rujkijyanont, Supak Ukritchon, et al. · Pediatric Blood & Cancer · 1

PDF

Relative Survival Rates of Pediatric Patients with Solid Tumours in Khon Kaen, Thailand

2026 · Surachai Phimha, Prapassara Sirikarn, et al. · Asian Pacific Journal of Cancer Prevention

PDF

ภาวะเลือดออกในสมองจากภาวะขาดวิตามินเคเนื่องจากโรคท่อน้ำดีตีบตัน

2022 · Jakaew, Chaniya, Chainansamit, Su-on, et al. · Thai Journal of Pediatrics

PDF

รายงานผู้ป่วยเด็ก Marfan Syndrome และ Deep Vein Thrombosis และ Acute myeloid leukemia

2021 · Kuakpetoon, Pakin, Chainansamit, Su-on, et al. · Thai Journal of Pediatrics

PDF

Works count: 16

Citation count: 146

H-index: 7

I10-index: 5